Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.96 USD | +0.01% | +0.40% | +240.82% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 23.6M | Sales 2025 * | 20.2M | Capitalization | 4.46B |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -110M | EV / Sales 2024 * | 179 x |
Net cash position 2024 * | 233M | Net cash position 2025 * | 208M | EV / Sales 2025 * | 210 x |
P/E ratio 2024 * |
-53.4
x | P/E ratio 2025 * |
-36.8
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.52% |
Latest transcript on Alpine Immune Sciences, Inc.
1 week | +0.48% | ||
Current month | +0.56% | ||
1 month | +0.90% | ||
3 months | +122.97% | ||
6 months | +443.06% | ||
Current year | +240.77% |
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
Director of Finance/CFO | - | 17-05-31 | |
Stanford Peng
PSD | President | 53 | 17-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Conway
BRD | Director/Board Member | 70 | 17-06-30 |
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
James Topper
BRD | Director/Board Member | 62 | 16-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.94% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 64.96 | +0.02% | 1 014 269 |
24-05-14 | 64.95 | 0.00% | 1,045,402 |
24-05-13 | 64.95 | +0.02% | 2,966,655 |
24-05-10 | 64.94 | +0.19% | 3,047,933 |
24-05-09 | 64.82 | +0.19% | 1,141,451 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.77% | 4.46B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- ALPN Stock